Treatment-resistant depression and peripheral C-reactive protein.
Chamberlain SR, Cavanagh J, de Boer P, Mondelli V, Jones DNC, Drevets WC, Cowen PJ, Harrison NA, Pointon L, Pariante CM, Bullmore ET. · 2019
Read Treatment-resistant depression and peripheral C-reactive protein. by Chamberlain SR, Cavanagh J, de Boer P, Mondelli V, Jones DNC, Drevets WC, Cowen PJ, Harrison NA, Pointon L, Pariante CM, Bullmore ET. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6124647.txt.
Description
Chamberlain and co-authors present a research article in The British Journal of Psychiatry on C-reactive protein and hard-to-treat depression. C-reactive protein, or CRP, is a blood marker of inflammation. It has been proposed as a marker for major depression. How it links to the varied forms of the illness was unclear.
The team studied 102 patients whose depression resisted treatment. They also studied responsive and untreated patients, plus healthy volunteers. CRP was higher in the resistant group, even after weight was factored in. High CRP also tracked with childhood hardship and certain symptoms. The authors suggest such patients might gain from anti-inflammatory drugs.
Catalog record
| CREATOR | Chamberlain SR, Cavanagh J, de Boer P, Mondelli V, Jones DNC, Drevets WC, Cowen PJ, Harrison NA, Pointon L, Pariante CM, Bullmore ET. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |